Pharmaceutical quality of docetaxel generics versus originator drug product: a comparative analysis

References

• Denis JN, Greene AE, Guenard D, . Highly efficient, practical approach to natural taxol. J Am Chem Soc 1988; 110:5917–9
   Web of Science ®Google Scholar
• Mangatal L, Adeline MT, Guenard D, . Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analogues. Tetrahedron 1989; 45:4177–90
   Web of Science ®Google Scholar
• Nogales E, Wolf SG, Downing KH. Structure of the alpha beta tubulin dimer by electron crystallography. Nature 1998; 391:199–203
   PubMed Web of Science ®Google Scholar
• Taxotere Summary of Product Characteristics. Available from http://www.emea.europa.eu/humandocs/PDFs/EPAR/taxotere/H-073-PI-en.pdf [Last accessed 4 Oct 2007]
   Google Scholar
• Gomez Y, Adams E, Hoogmartens J. Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand. J Pharm Biomed Anal 2004; 34:341–8
   PubMed Web of Science ®Google Scholar
• Nightingale CH. A survey of the quality of generic clarithromycin products from 18 countries. Clin Drug Investig 2005; 25:135–52
   PubMed Web of Science ®Google Scholar
• Nightingale CH. A survey of the quality of generic clarithromycin products from 13 countries. Clin Drug Investig 2000; 19:293–305
   Web of Science ®Google Scholar
• Trefi S, Gilard V, Malet-Martino M, . Generic ciprofloxacin tablets contain the stated amount of drug and different impurity profiles: a 19F, 1H and DOSY NMR analysis. J Pharm Biomed Anal 2007; 44:743–54
   PubMed Web of Science ®Google Scholar
• US Pharmacopeia.Monograph: paclitaxel injection, 2006
   Google Scholar
• International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Topic Q3B (R2): impurities in new drug productsGeneva. 2006
   Google Scholar
• International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Topic Q3A (R2): impurities in new drug substancesGeneva. 2006
   Google Scholar
• Rao BM, Chakraborty A, Srinivasu MK, . A stability-indicating HPLC assay method for docetaxel. J Pharm Biomed Anal 2006; 41:676–81
   PubMed Web of Science ®Google Scholar
• Vasu Dev R, Moses Babu J, Vyas K, . Isolation and characterization of impurities in docetaxel. J Pharm Biomed Anal 2006; 40:614–22
   PubMed Web of Science ®Google Scholar
• Kumar D, Tomar RS, Deolia SK, . Isolation and characterization of degradation impurities in docetaxel drug substance and its formulation. J Pharm Biomed Anal 2007; 43:1228–35
   PubMed Web of Science ®Google Scholar
• Le Mapihan K, Vial J, Jardy A. Reversed-phase liquid chromatography testing. Role of organic solvent through an extended set of columns. J Chromatogr A 2005; 1088:16–23
   PubMed Web of Science ®Google Scholar
• Wang T. Encyclopedia of chromatographyNew York: Marcel Dekker, 2001;245. 691–3
   Google Scholar
• Cuadros-Rodríguez L, Bagur-Gonzalez MG, Sanchez-Vinas M, . Principles of analytical calibration/quantification for the separation sciences. J Chromatogr A 2007; 1158:33–46
   PubMed Web of Science ®Google Scholar
• Vial J, Jardy A. Encyclopedia of ChromatographyNew York: Marcel Dekker, 2001;245–695
   Google Scholar
• International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Topic Q2 (R1): validation of analytical procedures: text and methodologyGeneva. 2005
   Google Scholar
• Massart DL, Vandeginste BGM, Buydens LMC, . Handbook of chemometrics and qualimetrics: part AMassart DL, Vandeginste BGM, Buydens LMC, Jong SD, Lewi PJ, Smeyers-Verbeke J. Amsterdam: Elsevier, 1997;788–90
   Google Scholar
• Derringer G, Suich R. Simultaneous optimization of several response variables. J Qual Technol 1980; 12:214–9
   Web of Science ®Google Scholar
• Rägo L. Global disequilibrium of quality. Pharmaceutical qualityPrince R. River Grove, IL, USA: David Horwood International Publishing Ltd, 2004
   Google Scholar
• Layoff T. Drug manufacture, industrial pharmacy considerations, quality assurance, and regulation. A slide program from the Johns Hopkins Bloomberg School of Public Health 2006. Available from http://ocw.jhsph.edu/courses/pharmaceuticalsmanagementforunder-servedpopulations/PDFs/Session3.pdf [Last accessed 18 Feb 2007]
   Google Scholar
• Newton PN, Green MD, Fernández FM, . Counterfeit anti-infective drugs. Lancet Infect Dis 2006; 6:602–13
   PubMed Web of Science ®Google Scholar
• Boven K, Stryker S, Knight J, . The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes. Kidney Int 2005; 67:2346–53
   PubMed Web of Science ®Google Scholar
• Limaye S, Steele RH, Quin J, . An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity. J Allergy Clin Immunol 2002; 110:530
   PubMed Web of Science ®Google Scholar
• Kowey PR. Issues in bioequivalence and generic substitution for antiarrhythmic drugs (editorial). Available from http://www.americanheart.org/presenter.jhtml?identifier=3015266 [Last accessed 18 Feb 2007]
   Google Scholar
• Reiffel JA. Formulation substitution and other pharmacokinetic variability: underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice. Am J Cardiol 2000; 85:46–52
   Web of Science ®Google Scholar
• Gross R. New findings in epilepsy from the 60th Annual Meeting of the American Epilepsy Society: an expert interview. Medscape Neurol Neurosurg 2006; 8: Available from http://www.medscape.com/viewarticle/549148 [Last accessed 18 Feb 2007]
   Google Scholar
• Crawford P, Feely M, Guberman A, . Are there potential problems with generic substitution of antiepileptic drugs? A review of issues. Seizure 2006; 15:165–76
   PubMed Web of Science ®Google Scholar
• Bayer Healthcare Pharmaceuticals.. Important Leukine safety information: US market withdrawal and replacement for Liquid Leukine. Available from http://www.fda.gov/CDER/drug/shortages/leukine_DHCP_Instructions_Formulation.pdf [Last accessed 24 Apr 2008]
   Google Scholar
• Bruno R, Vivier N, Veyrat-Follet C, . Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel. Invest New Drugs 2001; 19:163–9
   PubMed Web of Science ®Google Scholar
• Vial J, Sassiat P, Cohen M, . Quality of docetaxel generics versus Taxotere®: a comparative study. 12th International Meeting on Recent Developments in Pharmaceutical AnalysisIsland of Elba, Italy23–26 September, 2007. [abstract P088]
   Google Scholar
• Vial J, Sassiat P, Cohen M, . Quality of docetaxel generics versus originator drug product: a comparative study. 42nd American Society of Hospital Pharmacy Midyear Clinical Meeting and ExhibitionLas Vegas, NV, USA2–7 December, 2007. [abstract P543E]
   Google Scholar